Thomas Raueiser

Rethinking heart-lung support: We focus on the essential requirements of patients and their treating physicians in situations where extracorporeal support is critical. With our innovations and solutions, we redefine the field of Extracorporeal Life Support (ECLS and ECMO) – full attention, strict focus, easy access.

evoxx technologies GmbH, a German Industrial Biotechnology Company, is focusing on the development and production of industrial enzymes. As European subsidiary of the global enzyme manufacturer Advanced Enzymes Technologies Ltd. a comprehensive product portfolio of enzymatic solutions for human nutrition, animal nutrition, bio-processing and pharma industries is offered. Product development is based on the proprietary technology platform covering the whole value chain from early enzyme and process development to industrial scale production and product deregulation. evoxx industrial partners and customers benefit from the unique metagenomics libraries, the enzyme development skills and tech-transfer and production capabilities. evoxx is located on the Creative Campus in Monheim am Rhein and on the Biotech Campus Hermannswerder in Potsdam.

Founded in 1997, Pan-European VC Earlybird backs exceptional early-stage companies, supporting them through their growth and development phases and providing financial resources, strategic support, plus access to an international network and capital markets. Through two separate strategies, Earlybird focuses on tech-enabled businesses across software applications, infrastructure, and deep tech, while Earlybird Health focuses on life science breakthroughs accelerated by data-driven analytics and operations. Earlybird also has a pro-bono impact initiative, Vision Lab. With EUR 2.5 billion under management across fund streams and a history of 9 IPOs and 37 trade sales, Earlybird is among Europe’s most established and active venture capital firms. More information: www.earlybird.com X: https://x.com/EarlybirdVC LinkedIn:www.linkedin.com/company/earlybird-venture-capital Instagram: https://www.instagram.com/earlybirdvc/

The focus of the company is the development, demonstration of clinical benefit, and early-stage commercialization of cryotherapy systems for the treatment of coronary plaque.

Gründerfonds Ruhr is a private venture capital fund driving innovation in the Ruhr area by investing in new technologies impacting a broad range of industries. We deploy the capital, the business expertise and the industry access from leading international corporations who share our goal of building Ruhr-based start-ups with transforming ideas. Our objective is to be the institutional investor of choice for founders and become a trusted partner with the resources to catapult young companies to their next stage of development and commercial success. Our long-term vision is to thereby boost entrepreneurial spirit in our region. Key sectors include chemicals & new materials, energy & industrial sector, life sciences & healthcare, logistics & retail and the digital economy. Our current portfolio consists of Abalos Therapeutics, DIMATE, Emergence Therapeutics, Fasciotens, Masterplan.com and talpasolutions. For further information: www.gruenderfonds-ruhr.com

Rethinking heart-lung support: We focus on the essential requirements of patients and their treating physicians in situations where extracorporeal support is critical. With our innovations and solutions, we redefine the field of Extracorporeal Life Support (ECLS and ECMO) – full attention, strict focus, easy access.

evoxx technologies GmbH, a German Industrial Biotechnology Company, is focusing on the development and production of industrial enzymes. As European subsidiary of the global enzyme manufacturer Advanced Enzymes Technologies Ltd. a comprehensive product portfolio of enzymatic solutions for human nutrition, animal nutrition, bio-processing and pharma industries is offered. Product development is based on the proprietary technology platform covering the whole value chain from early enzyme and process development to industrial scale production and product deregulation. evoxx industrial partners and customers benefit from the unique metagenomics libraries, the enzyme development skills and tech-transfer and production capabilities. evoxx is located on the Creative Campus in Monheim am Rhein and on the Biotech Campus Hermannswerder in Potsdam.